Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity

Abstract

This study provides Class IV evidence that, for patients with limb spasticity, escalating incobotulinumtoxinA doses (400 U up to 800 U) increases treatment efficacy without compromising safety or tolerability.